0H7I Stock Overview Operates as a specialty chemicals company that engages in the development, manufacture, and marketing of chemical intermediates, additives, specialty chemicals, and consumer protection products worldwide. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
LANXESS Aktiengesellschaft Competitors Price History & Performance
Summary of share price highs, lows and changes for LANXESS Historical stock prices Current Share Price €23.41 52 Week High €29.83 52 Week Low €21.00 Beta 1.62 1 Month Change -10.75% 3 Month Change -19.59% 1 Year Change -13.26% 3 Year Change -59.12% 5 Year Change -59.60% Change since IPO -13.08%
Recent News & Updates LANXESS Aktiengesellschaft to Report Q1, 2025 Results on May 08, 2025
Third quarter 2024 earnings released: EPS: €0.01 (vs €1.52 loss in 3Q 2023) Nov 08 UBE Corporation (TSE:4208) signed a contract to acquire Urethane Systems Business of LANXESS Aktiengesellschaft (XTRA:LXS) for an enterprise value of €460 million. Oct 04
Second quarter 2024 earnings released: €0.19 loss per share (vs €1.68 loss in 2Q 2023) Aug 11
LANXESS Aktiengesellschaft Announces Executive Changes Jul 10
Upcoming dividend of €0.10 per share May 20 See more updates LANXESS Aktiengesellschaft to Report Q1, 2025 Results on May 08, 2025
Third quarter 2024 earnings released: EPS: €0.01 (vs €1.52 loss in 3Q 2023) Nov 08 UBE Corporation (TSE:4208) signed a contract to acquire Urethane Systems Business of LANXESS Aktiengesellschaft (XTRA:LXS) for an enterprise value of €460 million. Oct 04
Second quarter 2024 earnings released: €0.19 loss per share (vs €1.68 loss in 2Q 2023) Aug 11
LANXESS Aktiengesellschaft Announces Executive Changes Jul 10
Upcoming dividend of €0.10 per share May 20
First quarter 2024 earnings released: €1.13 loss per share (vs €0.12 profit in 1Q 2023) May 08
Dividend reduced to €0.10 Apr 14
Full year 2023 earnings released: €9.76 loss per share (vs €2.13 profit in FY 2022) Mar 17 Lanxess Reportedly Seeks to Sell Polyurethane Ops Jan 16
New major risk - Revenue and earnings growth Dec 01
New major risk - Revenue and earnings growth Nov 13
Third quarter 2023 earnings released: €1.52 loss per share (vs €0.97 profit in 3Q 2022) Nov 09
LANXESS Aktiengesellschaft Proposes Dividend for the Fiscal Year 2023 Nov 07 LANXESS Aktiengesellschaft to Report Q1, 2024 Results on May 08, 2024 LANXESS Aktiengesellschaft(XTRA:LXS) dropped from FTSE All-World Index (USD) Sep 18
New major risk - Revenue and earnings growth Sep 13
New major risk - Dividend sustainability Aug 07
Now 21% undervalued after recent price drop Aug 07
Second quarter 2023 earnings released Aug 05
Now 32% undervalued after recent price drop Jun 21
Investor sentiment deteriorates as stock falls 19% Jun 20
Upcoming dividend of €1.05 per share at 3.0% yield May 18
Now 20% undervalued after recent price drop May 11
First quarter 2023 earnings released: EPS: €0.12 (vs €0.76 in 1Q 2022) May 11
Now 23% undervalued after recent price drop Apr 05
Full year 2022 earnings released: EPS: €2.13 (vs €2.54 in FY 2021) Mar 16
Now 20% undervalued Feb 24
Investor sentiment improved over the past week Jan 05
Third quarter 2022 earnings released: EPS: €0.97 (vs €0.46 in 3Q 2021) Nov 11
Second quarter 2022 earnings released: EPS: €0.56 (vs €0.54 in 2Q 2021) Aug 08
LANXESS Aktiengesellschaft (XTRA:LXS) completed the acquisition of Microbial Control business unit of International Flavors & Fragrances Inc. (NYSE:IFF). Jul 02
Investor sentiment deteriorated over the past week Jun 16 LANXESS Aktiengesellschaft to Report Q3, 2023 Results on Nov 08, 2023 Advent International Corporation and LANXESS Aktiengesellschaft (XTRA:LXS) agreed to acquire Engineering Materials business of Royal DSM from Koninklijke DSM N.V. (ENXTAM:DSM) for €3.9 billion. Jun 01
Investor sentiment improved over the past week May 31
Upcoming dividend of €1.05 per share May 19
First quarter 2022 earnings released: EPS: €1.13 (vs €0.73 in 1Q 2021) May 06
LANXESS Aktiengesellschaft Provides Financial Guidance for the First Quarter of 2022 Apr 20
Full year 2021 earnings: Revenues exceed analyst expectations Mar 15
Investor sentiment improved over the past week Mar 14
Investor sentiment deteriorated over the past week Feb 24
LANXESS Announces Executive Changes Feb 16
Lanxess Reportedly Teams Up with Advent to Bid for DSM's Materials Ops Feb 01
Second quarter 2021 earnings released: EPS €0.89 (vs €9.32 in 2Q 2020) Aug 13
TFL Ledertechnik GmbH completed the acquisition of organic leather chemicals business from LANXESS Aktiengesellschaft (XTRA:LXS). Jun 02
First quarter 2021 earnings released May 13
Upcoming dividend of €1.00 per share May 13
Full year 2020 earnings released: EPS €10.30 (vs €2.89 in FY 2019) Mar 12
Revenue beats expectations Mar 12
New 90-day high: €66.53 Mar 09
LANXESS Aktiengesellschaft (XTRA:LXS) completed the acquisition of Intace SAS. Mar 03
Lanxess Announces Executive Changes Feb 06
LANXESS Aktiengesellschaft (XTRA:LXS) signed an agreement to acquire Intace SAS. Jan 16
New 90-day high: €64.13 Jan 14
LANXESS Starts Talks to Acquire Theseo Jan 13
Suez SA (ENXTPA:SEV) completed the acquisition of reverse osmosis membranes business from LANXESS Aktiengesellschaft (XTRA:LXS). Jan 05
New 90-day high: €63.98 Dec 29
Lanxess Reportedly to Bid for Emerald Kalama Chemical Dec 17
New 90-day high: €60.82 Dec 08
New 90-day high: €53.32 Nov 16
Third quarter 2020 earnings released: EPS €0.30 Nov 07
Revenue misses expectations Nov 07
New 90-day low: €43.46 Oct 29
LANXESS Aktiengesellschaft to Report Q3, 2020 Results on Nov 05, 2020 Oct 01
New 90-day high - €51.78 Sep 12 LANXESS Aktiengesellschaft to Report Q3, 2021 Results on Nov 04, 2021
Earnings released Aug 16
TFL Ledertechnik GmbH signed an agreement to acquire organic leather chemicals business from LANXESS Aktiengesellschaft (XTRA:LXS) for approximately €200 million. Aug 14
Funds managed by Macquarie Infrastructure and Real Assets completed the acquisition of remaining 40% stake in Currenta GmbH & Co. OHG from LANXESS Aktiengesellschaft (XTRA:LXS) for €780 million. Jul 31
Suez SA (ENXTPA:SEV) signed an agreement to purchase reverse osmosis membranes business from LANXESS Aktiengesellschaft (XTRA:LXS). Jul 18 Shareholder Returns 0H7I GB Chemicals GB Market 7D 0.4% -1.4% 1.3% 1Y -13.3% -22.0% 4.3%
See full shareholder returns
Return vs Market: 0H7I underperformed the UK Market which returned 3.9% over the past year.
Price Volatility Is 0H7I's price volatile compared to industry and market? 0H7I volatility 0H7I Average Weekly Movement 5.3% Chemicals Industry Average Movement 6.0% Market Average Movement 4.7% 10% most volatile stocks in GB Market 10.5% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: 0H7I has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0H7I's weekly volatility (5%) has been stable over the past year.
About the Company Founded Employees CEO Website 1863 12,849 Frederique van Baarle lanxess.com
LANXESS Aktiengesellschaft, together with its subsidiaries, operates as a specialty chemicals company that engages in the development, manufacture, and marketing of chemical intermediates, additives, specialty chemicals, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The Consumer Protection segment provides material protection products; disinfectant, hygiene, and preservative solutions; flavors and fragrances; liquid purification technologies for the treatment of water and other liquids; and precursors and intermediates for the agrochemicals, pharmaceuticals, and specialty chemicals industries.
Show more LANXESS Aktiengesellschaft Fundamentals Summary How do LANXESS's earnings and revenue compare to its market cap? 0H7I fundamental statistics Market cap €2.04b Earnings (TTM ) -€690.00m Revenue (TTM ) €6.32b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 0H7I income statement (TTM ) Revenue €6.32b Cost of Revenue €5.09b Gross Profit €1.23b Other Expenses €1.92b Earnings -€690.00m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 20, 2025
Earnings per share (EPS) -7.99 Gross Margin 19.39% Net Profit Margin -10.92% Debt/Equity Ratio 68.8%
How did 0H7I perform over the long term?
See historical performance and comparison Dividends
0.4% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/02 07:31 End of Day Share Price 2025/01/02 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources LANXESS Aktiengesellschaft is covered by 52 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Martin Schnee AlphaValue Heiko Feber Bankhaus Lampe KG James Knight Barclays
Show 49 more analysts 
